- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有51家主力机构披露2026-06-30报告期持股数据，持仓量总计2.00亿股，占流通A股33.91%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了68%的股票
技术面评分前10的股票
近期的平均成本为4.86元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为4.86元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.86","date":1794471243,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.11.13","stock":"-2.43","trade":"-3.11","ind":"-2.05"},{"date":"2026.11.12","stock":"-1.00","trade":"-0.34","ind":"-1.68"},{"date":"2026.11.11","stock":"1.22","trade":"0.01","ind":"1.32"},{"date":"2026.11.10","stock":"2.07","trade":"0.54","ind":"0.86"},{"date":"2026.11.09","stock":"-1.63","trade":"-0.42","ind":"-0.27"},{"date":"2026.11.06","stock":"-0.81","trade":"-2.28","ind":"-2.57"},{"date":"2026.11.05","stock":"1.65","trade":"2.50","ind":"1.19"},{"date":"2026.11.04","stock":"1.25","trade":"4.12","ind":"4.22"},{"date":"2026.11.03","stock":"-0.41","trade":"-1.89","ind":"-1.21"},{"date":"2026.11.02","stock":"2.12","trade":"1.53","ind":"1.63"},{"date":"2026.10.30","stock":"-2.28","trade":"-0.95","ind":"-2.73"},{"date":"2026.10.29","stock":"-0.41","trade":"-2.31","ind":"-2.92"},{"date":"2026.10.28","stock":"1.04","trade":"2.17","ind":"2.02"},{"date":"2026.10.27","stock":"-3.23","trade":"-4.09","ind":"-2.50"},{"date":"2026.10.26","stock":"3.12","trade":"0.93","ind":"-1.19"},{"date":"2026.10.23","stock":"-0.62","trade":"1.99","ind":"2.79"},{"date":"2026.10.22","stock":"-2.42","trade":"-3.56","ind":"-2.96"},{"date":"2026.10.21","stock":"-0.20","trade":"0.04","ind":"-0.82"},{"date":"2026.10.20","stock":"0.61","trade":"1.25","ind":"-0.14"},{"date":"2026.10.19","stock":"-2.56","trade":"-0.59","ind":"0.13"},{"date":"2026.10.16","stock":"-1.36","trade":"-1.26","ind":"-0.12"}]
东宝生物,深证成指,生物制品指数
压力支撑
该股压力位为4.85元，支撑位为4.77元。
[{"text":"\u538b\u529b\u4f4d","value":"4.85","date":1794499200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.77","date":1794499200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了39%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月13日 20:30
| 机构今日流向(万元) | -2729.47 | 机构5日流向(万元) | -7437.83 |
| 机构10日流向(万元) | -3863.60 | 机构20日流向(万元) | -8013.22 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加127.41万股，其中基金数没有增加，主力净减仓10家，暂未发现中长期投资价值。
截止2026-06-30，共51家主力机构（基金46家，社保基金1家，一般法人3家，阳光私募1家），持仓量总计20000.88万股，占流通A股33.91%
其中，基金持仓与2025-12-31相比：
增仓：7家 ，增持 5.96万股
减仓：7家 ，减持 60.35万股
新出现在主力名单中：31家 ，持有406.96万股
从主力名单中消失：41家 ，原持有225.16万股
其中，基金持仓与2025-12-31相比：
增仓：7家 ，增持 5.96万股
减仓：7家 ，减持 60.35万股
新出现在主力名单中：31家 ，持有406.96万股
从主力名单中消失：41家 ，原持有225.16万股
消息面诊股
诊断结果：5.5消息面打败了30%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 高盛出手抄底A股82个股票，直接买成十大股东，集中
2026-11-10 - 东宝生物2026年前三季度实现营收6.23亿元
2026-10-26 - 股东追踪|高盛公司有限责任公司等新进东宝生物前十大
2026-10-23 - 东宝生物：2026年第三季度归属于上市公司股东的净
2026-10-23 - 东宝生物：第十届董事会第四次会议决议公告
2026-10-23 - 财报速递：东宝生物2026年前三季度净利润5494
2026-10-26 - 东宝生物（截止2026年9月30日）股东人数为20
2026-10-23 - 东宝生物前三季度营业收入6.23亿元，同比增长16
2026-10-23 - 【商品涨跌排行榜】烟酰胺现货单日大涨8.71%！报
2026-10-16 - 东宝生物：华北、华东地区毛利率出现差异的原因主要是
2026-09-07
消息列表
| 一般消息 | 募资投向 | 2026-09-21 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-24 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-30 |
| 利好 | 分红转增 | 10派0.12元(含税) | 2026-03-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了71%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.11.13","price":"-2.05","value":"-3.11"},{"date":"2026.11.12","price":"-1.68","value":"-0.34"},{"date":"2026.11.11","price":"1.32","value":"0.01"},{"date":"2026.11.10","price":"0.86","value":"0.54"},{"date":"2026.11.09","price":"-0.27","value":"-0.42"},{"date":"2026.11.06","price":"-2.57","value":"-2.28"},{"date":"2026.11.05","price":"1.19","value":"2.50"},{"date":"2026.11.04","price":"4.22","value":"4.12"},{"date":"2026.11.03","price":"-1.21","value":"-1.89"},{"date":"2026.11.02","price":"1.63","value":"1.53"},{"date":"2026.10.30","price":"-2.73","value":"-0.95"},{"date":"2026.10.29","price":"-2.92","value":"-2.31"},{"date":"2026.10.28","price":"2.02","value":"2.17"},{"date":"2026.10.27","price":"-2.50","value":"-4.09"},{"date":"2026.10.26","price":"-1.19","value":"0.93"},{"date":"2026.10.23","price":"2.79","value":"1.99"},{"date":"2026.10.22","price":"-2.96","value":"-3.56"},{"date":"2026.10.21","price":"-0.82","value":"0.04"},{"date":"2026.10.20","price":"-0.14","value":"1.25"},{"date":"2026.10.19","price":"0.13","value":"-0.59"},{"date":"2026.10.16","price":"-0.12","value":"-1.26"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康弘药业 | 15.38% | -2.52% | 5.8分 |
| 2 | 我武生物 | 14.94% | -3.77% | 5.5分 |
| 3 | 禾元生物 | 10.76% | 18.16% | 7.0分 |
| 4 | 智飞生物 | 10.18% | -7.11% | 5.4分 |
| 5 | 智翔金泰 | 10.09% | -4.78% | 6.1分 |
| 6 | 西藏药业 | 8.88% | -2.85% | 6.3分 |
| 8 | 欧林生物 | 1.60% | -5.36% | 5.9分 |
| 10 | 君实生物 | -0.57% | -3.40% | 6.1分 |
| 12 | 百奥泰 | -1.24% | -5.91% | 5.8分 |
| 14 | 天坛生物 | -2.75% | -5.21% | 5.0分 |
| 16 | 近岸蛋白 | -3.40% | 6.37% | 4.3分 |
| 18 | 派林生物 | -3.85% | -7.51% | 4.6分 |
| 20 | 荣昌生物 | -4.11% | 0.72% | 6.6分 |
| 22 | 赛伦生物 | -4.33% | -4.36% | 4.7分 |
| 24 | 康泰生物 | -4.76% | -7.73% | 4.4分 |
| 26 | - | -5.06% | -3.68% | 分 |
| 28 | 博雅生物 | -5.13% | -6.60% | 4.2分 |
| 30 | 康华生物 | -5.87% | -6.99% | 4.7分 |
| 32 | 信诺维 | -6.28% | -8.89% | 5.5分 |
| 34 | 卫光生物 | -6.49% | -3.74% | 5.2分 |
| 36 | 三生国健 | -7.47% | -3.58% | 6.1分 |
| 38 | 四环生物 | -8.51% | -2.27% | 4.6分 |
| 40 | 华兰生物 | -8.75% | -4.23% | 4.0分 |
| 42 | - | -9.06% | -4.02% | 分 |
| 44 | 双成药业 | -9.24% | 9.90% | 5.6分 |
| 46 | *ST未名 | -9.54% | 6.86% | 5.6分 |
| 48 | - | -10.81% | -3.99% | 分 |
| 50 | 义翘神州 | -14.20% | -6.93% | 4.4分 |
| 52 | 艾迪药业 | -16.62% | -1.53% | 5.0分 |
| 54 | 沃森生物 | -18.84% | -5.94% | 4.3分 |
| 56 | 科兴制药 | -24.64% | -2.12% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 21/74 ， 48/74。
[{"date":"2026-09-30","value":"3.14","vol":"-8.23"},{"date":"2026-06-30","value":"2.15","vol":"-7.86"},{"date":"2026-03-31","value":"1.14","vol":"-6.34"},{"date":"2025-12-31","value":"3.14","vol":"-12.02"},{"date":"2025-09-30","value":"2.80","vol":"-9.71"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.14 | 2.15 | 1.14 | 3.14 | 2.80 |
| 行业(%) | -8.23 | -7.86 | -6.34 | -12.02 | -9.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"22.59","vol":"53.64"},{"date":"2026-06-30","value":"22.08","vol":"56.17"},{"date":"2026-03-31","value":"24.29","vol":"60.27"},{"date":"2025-12-31","value":"23.36","vol":"65.27"},{"date":"2025-09-30","value":"24.53","vol":"67.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
22.59 | 22.08 | 24.29 | 23.36 | 24.53 |
| 行业(%) | 53.64 | 56.17 | 60.27 | 65.27 | 67.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，两项指标的行业排名分别为 17/74 ， 20/74。
[{"date":"2026-09-30","value":"16.86","vol":"17.56"},{"date":"2026-06-30","value":"12.37","vol":"30.57"},{"date":"2026-03-31","value":"1.32","vol":"291.45"},{"date":"2025-12-31","value":"-15.78","vol":"39.10"},{"date":"2025-09-30","value":"-15.84","vol":"44.08"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
16.86 | 12.37 | 1.32 | -15.78 | -15.84 |
| 行业(%) | 17.56 | 30.57 | 291.45 | 39.10 | 44.08 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"13.40","vol":"44.90"},{"date":"2026-06-30","value":"1.18","vol":"18.61"},{"date":"2026-03-31","value":"3.41","vol":"71.92"},{"date":"2025-12-31","value":"-36.80","vol":"36.03"},{"date":"2025-09-30","value":"-26.89","vol":"43.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.40 | 1.18 | 3.41 | -36.80 | -26.89 |
| 行业(%) | 44.90 | 18.61 | 71.92 | 36.03 | 43.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 19/74 ， 11/74。
[{"date":"2026-09-30","value":"0.24","vol":"0.21"},{"date":"2026-06-30","value":"0.16","vol":"0.14"},{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.29","vol":"0.30"},{"date":"2025-09-30","value":"0.21","vol":"0.21"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.16 | 0.07 | 0.29 | 0.21 |
| 行业(次) | 0.21 | 0.14 | 0.06 | 0.30 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.16","vol":"0.98"},{"date":"2026-06-30","value":"0.81","vol":"0.62"},{"date":"2026-03-31","value":"0.35","vol":"0.28"},{"date":"2025-12-31","value":"1.51","vol":"1.26"},{"date":"2025-09-30","value":"1.04","vol":"0.86"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.16 | 0.81 | 0.35 | 1.51 | 1.04 |
| 行业(次) | 0.98 | 0.62 | 0.28 | 1.26 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"4.33","vol":"-2949.98"},{"date":"2026-06-30","value":"14.98","vol":"-1266.35"},{"date":"2026-03-31","value":"10.99","vol":"-144.81"},{"date":"2025-12-31","value":"20.94","vol":"-237.25"},{"date":"2025-09-30","value":"6.79","vol":"-11.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 4.33 | 14.98 | 10.99 | 20.94 | 6.79 |
| 行业 | -2949.98 | -1266.35 | -144.81 | -237.25 | -11.00 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"1.81","vol":"1.58"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.81","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.81 | - | 0.81 | - |
| 行业 | 0.00 | 1.58 | 0.00 | 1.73 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 26/74 ， 23/74。
[{"date":"2026-09-30","value":"4.08","vol":"5.72"},{"date":"2026-06-30","value":"4.22","vol":"5.75"},{"date":"2026-03-31","value":"4.81","vol":"6.58"},{"date":"2025-12-31","value":"4.87","vol":"5.74"},{"date":"2025-09-30","value":"4.90","vol":"5.84"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.08 | 4.22 | 4.81 | 4.87 | 4.90 |
| 行业 | 5.72 | 5.75 | 6.58 | 5.74 | 5.84 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.46","vol":"4.34"},{"date":"2026-06-30","value":"2.73","vol":"4.33"},{"date":"2026-03-31","value":"3.00","vol":"5.09"},{"date":"2025-12-31","value":"3.12","vol":"4.39"},{"date":"2025-09-30","value":"3.07","vol":"4.70"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.46 | 2.73 | 3.00 | 3.12 | 3.07 |
| 行业 | 4.34 | 4.33 | 5.09 | 4.39 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 16/74 ， 19/74。
[{"date":"2026-09-30","value":"32.15","vol":"29.36"},{"date":"2026-06-30","value":"33.23","vol":"29.58"},{"date":"2026-03-31","value":"32.29","vol":"29.49"},{"date":"2025-12-31","value":"32.42","vol":"29.33"},{"date":"2025-09-30","value":"32.50","vol":"26.96"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.15 | 33.23 | 32.29 | 32.42 | 32.50 |
| 行业(%) | 29.36 | 29.58 | 29.49 | 29.33 | 26.96 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.47","vol":"1.84"},{"date":"2026-06-30","value":"0.50","vol":"1.35"},{"date":"2026-03-31","value":"0.48","vol":"2.52"},{"date":"2025-12-31","value":"0.48","vol":"1.42"},{"date":"2025-09-30","value":"0.48","vol":"0.56"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.47 | 0.50 | 0.48 | 0.48 | 0.48 |
| 行业(%) | 1.84 | 1.35 | 2.52 | 1.42 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"1.09","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.54","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]